{"nct_id":"NCT00695396","title":"A Study Evaluating Epoetin Alfa 40,000 IU (International Units) Every Week or 80,000 IU Every Week Compared to Placebo in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes at Risk for Transfusion","status":"TERMINATED","status_verified_date":"2012-10","start_date":"2008-06","start_date_type":null,"primary_completion_date":"2010-01","primary_completion_date_type":"ACTUAL","completion_date":"2010-01","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}